Priser
Platform
Blog
Om os
Download
300482
Guangzhou Wondfo Biotech Co
Shenzhen Stock Exchange
0

Om

Guangzhou Wondfo Biotech Co., Ltd. is a biotechnology company specializing in the research, development, and manufacture of medical diagnostic products. The company focuses on creating innovative solutions in the health sector, offering a wide range of test kits and devices for detecting various conditions and diseases. Their products include diagnostic tools for pregnancy and fertility, infectious diseases, drug abuse, and more, addressing critical health monitoring needs in medical facilities, clinics, and laboratories.

Wondfo Biotech plays a significant role in the healthcare industry by providing quick and reliable diagnostic results, which are essential for effective disease management and patient care. The company's commitment to quality and innovation supports the growing demand for advanced healthcare solutions globally. Headquartered in Guangzhou, China, Wondfo Biotech has established a robust market presence, distributing its products internationally and maintaining a reputation for excellence in the biotech field.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I GUANGZHOU WONDFO BIOTECH CO MED ENDAVU: Køb Guangzhou Wondfo Biotech Co ($300482) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Guangzhou Wondfo Biotech Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker300482
Land
Kina
Antal medarbejdere3.197
Hjemmesidewondfo.com.cn
SektorSundhed
IndustriMedicinsk udstyr

Udbytter

0,19CNH
'20
0,38CNH
'21
0,3CNH
'22
0,5CNH
'23
0,4CNH
'24
0,4CNH
'25
Ex-udbytte-dato20. maj 2025
Udbytteafkast2,1%

Analytikerskøn

Baseret på 5 analytikere

Stærkt købKøbHoldSælgStærkt sælg
20%80%0%0%0%